CARDIFF ONCOLOGY INC (CRDF) Stock Analyst Ratings
USA - NASDAQ:CRDF - US14147L1089 - Common Stock
2.35 USD
+0.12 (+5.38%)
2.34 USD
-0.01 (-0.43%)
ChartMill assigns a Buy % Consensus number of 83% to CRDF. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.63. This target is 352.13% above the current price.
CRDF was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRDF.
In the previous month the buy percentage consensus was at a similar level.
CRDF was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-08 | Ladenburg Thalmann | Initiate | Buy |
| 2025-06-24 | Jefferies | Initiate | Hold |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-06 | Craig-Hallum | Initiate | Buy |
| 2024-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-29 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-07 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-13 | Piper Sandler | Maintains | Overweight |
| 2022-08-29 | Baird | Maintains | Outperform |
| 2022-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-28 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-08 | Baird | Initiate | Outperform |
| 2021-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-10 | HC Wainwright & Co. | Maintains | Buy |
CARDIFF ONCOLOGY INC / CRDF FAQ
Can you provide the average price target for CARDIFF ONCOLOGY INC stock?
14 analysts have analysed CRDF and the average price target is 10.63 USD. This implies a price increase of 352.13% is expected in the next year compared to the current price of 2.35.
How do analysts rate CARDIFF ONCOLOGY INC (CRDF)?
The consensus rating for CARDIFF ONCOLOGY INC (CRDF) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed CARDIFF ONCOLOGY INC (CRDF)?
The number of analysts covering CARDIFF ONCOLOGY INC (CRDF) is 14.